ストックスクリーナーアプリを入手
1.62
1.52%
-0.03
前日終値:
$1.65
開ける：
$1.66
24時間の取引高:
61,657
Relative Volume:
0.24
時価総額：
$87.03M
収益：
-
当期純損益:
$-31.39M
株価収益率:
-1.9286
EPS:
-0.84
ネットキャッシュフロー:
$-18.45M
1週間 パフォーマンス:
-9.22%
1か月 パフォーマンス:
-1.52%
6か月 パフォーマンス:
+53.30%
1年 パフォーマンス:
+5.52%
1日の値動き範囲:
$1.61
$1.6729
1週間の範囲:
$1.597
$1.79
52週間の値動き範囲:
$0.7203
$2.45
Quince Therapeutics Inc Stock (QNCX) Company Profile
名前
Quince Therapeutics Inc
セクター
電話
415-910-5717
住所
611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO
QNCX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QNCX
Quince Therapeutics Inc
|
1.6202 | 88.63M | 0 | -31.39M | -18.45M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.25 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.23 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.03 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
829.86 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.66 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Quince Therapeutics Inc Stock (QNCX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-05 | 開始されました | Citizens JMP | Mkt Outperform |
| 2025-03-24 | 開始されました | Oppenheimer | Outperform |
Quince Therapeutics Inc (QNCX) 最新ニュース
What indicators show strength in Quince Therapeutics Inc.2025 Support & Resistance & Capital Protection Trading Alerts - newser.com
Will earnings trigger a reversal in Quince Therapeutics Inc.Inflation Watch & Free Risk Controlled Daily Trade Plans - newser.com
Is Quince Therapeutics Inc. stock positioned for digital transformationTreasury Yields & Daily Market Momentum Tracking - newser.com
How Quince Therapeutics Inc. stock performs in rising dollar environmentTrade Volume Summary & Safe Entry Zone Tips - newser.com
Will Quince Therapeutics Inc. stock recover faster than peers2025 Market WrapUp & Community Trade Idea Sharing - newser.com
Can Quince Therapeutics Inc. stock double in next 5 yearsIPO Watch & Entry Point Strategy Guides - newser.com
Statistical indicators supporting Quince Therapeutics Inc.’s strengthJuly 2025 Catalysts & Free Safe Entry Trade Signal Reports - newser.com
Why retail investors favor Quince Therapeutics Inc. stockJuly 2025 Highlights & Low Risk Investment Opportunities - newser.com
What hedge fund activity signals for Quince Therapeutics Inc. stockQuarterly Growth Report & Free Reliable Trade Execution Plans - newser.com
How analysts rate Quince Therapeutics Inc. stock todayJuly 2025 PreEarnings & Precise Swing Trade Entry Alerts - newser.com
Is Quince Therapeutics Inc. stock cheap compared to fundamentalsWeekly Profit Recap & Pattern Based Trade Signal System - newser.com
Combining machine learning predictions for Quince Therapeutics Inc.Earnings Recap Report & Fast Gaining Stock Reports - newser.com
Quince Therapeutics Inc. stock volume spike explained2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
Is Quince Therapeutics Inc. showing signs of accumulationPrice Action & Safe Investment Capital Preservation Plans - newser.com
Is Quince Therapeutics Inc. stock ready for a breakoutMarket Growth Summary & Weekly Top Gainers Trade List - newser.com
Market reaction to Quince Therapeutics Inc.’s recent newsEarnings Trend Report & Daily Market Momentum Tracking - newser.com
How to forecast Quince Therapeutics Inc. trends using time seriesDip Buying & Verified Momentum Stock Watchlist - newser.com
Quince Therapeutics, Inc. (NASDAQ:QNCX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Quince Therapeutics Inc (QNCX) 財務データ
収益
当期純利益
現金流量
EPS
0.68%
0.96%
大文字化:
|
ボリューム (24 時間):